(Q33372069)

English

Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

Immune thrombocytopenic purpura

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Giovanna Russo

5

0 references

object named as

Paola Giordano

11

0 references

object named as

Simone Cesaro

9

0 references

object named as

Gianni Bisogno

10

0 references

Franco Locatelli

8

object named as

Franco Locatelli

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

object named as

Marco Zecca

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

object named as

Bruno Nobili

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Silverio Perrotta

3

object named as

Silverio Perrotta

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Emilia Parodi

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sofia Maria Rosaria Matarese

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Maria Licciardello

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Domenico De Mattia

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ugo Ramenghia

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

84

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

48-53

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective B cell depletion with rituximab in the treatment of autoimmune diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of childhood autoimmune haemolytic anaemia with rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune thrombocytopenic purpura

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab in children with idiopathic thrombocytopenic purpura: does it really work?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16867902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1532/IJH97.E0518

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33372069&oldid=2195296485"